Neuroprotective potential of ionotropic glutamate receptor antagonists

Neurotoxicity Research

Volumn 4, Issue 2, 2002, Pages 119-126

  Danysz, Wojciech ^a   Parsons, Chris G ^a  

^a MERZ PHARMACEUTICALS GMBH   (Germany)

Author keywords

AIDS; ALS; Alzheimer; AMPA; Glutamate; Huntington; Neuroprotection; NMDA; Parkinson; Stroke; Trauma

Indexed keywords

2 AMINO 4 METHYL 5 PHOSPHONO 3 PENTENOIC ACID; 4 BENZYL ALPHA (4 HYDROXYPHENYL) BETA METHYL 1 PIPERIDINEPROPANOL; 4 PHOSPHONOMETHYLPIPECOLIC ACID; 4,6 DICHLORO 3 (2 OXO 1 PHENYL 3 PYRROLIDINYLIDENEMETHYL) 1H INDOLE 2 CARBOXYLIC ACID; 6 NITRO 7 SULFAMOYLBENZO[F]QUINOXALINE 2,3 DIONE; 6,7 DICHLORO 5 NITRO 2,3 QUINOXALINEDIONE; 7 CHLORO 1,2,5,10 TETRAHYDRO 4 HYDROXY 2 (4 METHOXY 2 METHYLPHENYL)PYRIDAZINO[4,5 B]QUINOLINE 1,10 DIONE; [1,2,3,4 TETRAHYDRO 7 (1H IMIDAZOL 1 YL) 6 NITRO 2,3 DIOXO 1 QUINOXALINYL]ACETIC ACID; AMPA RECEPTOR ANTAGONIST; APTIGANEL; CNS 5161; DEXANABINOL; DEXTROMETHORPHAN; DIZOCILPINE; ELIPRODIL; GAVESTINEL; GLUTAMATE RECEPTOR ANTAGONIST; GLYCINE RECEPTOR ANTAGONIST; IONOTROPIC RECEPTOR ANTAGONIST; LANICEMINE; MAGNESIUM; MRZ 2; MRZ 2 576; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NERAMEXANE; PD 152247; REMACEMIDE; RILUZOLE; TRAXOPRODIL; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ACUTE DISEASE; AGITATION; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATAXIA; BRAIN INJURY; CHRONIC DISEASE; CLINICAL TRIAL; CONFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEGENERATIVE DISEASE; DISEASE COURSE; DRUG COST; DRUG MECHANISM; HALLUCINATION; HUMAN; HUMAN TISSUE; HUNTINGTON CHOREA; MUSCLE RELAXATION; NEUROPROTECTION; NONHUMAN; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RAT; STROKE; VERTIGO;

ANIMALIA;

EID: 0036203057     PISSN: 10298428     EISSN: None     Source Type: Journal    
DOI: 10.1080/10298420290015872     Document Type: Article

References (77)

1. "Role of NMDA and non-NMDA ionotropic glutamate receptors in traumatic spinal cord axonal injury"
2. "Riluzole prevents MPTP-induced Parkinsonism in the rhesus monkey: A pilot study"
3. "A controlled trial of Riluzole in amyotrophic sclerosis"
4. "Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis"
5. "Traumatic brain damage prevented by the non-N-methyl-D-aspartate antagonist 2,3-dihydroxy-6-nitro-7-sulfamoylbenzo[f]quinoxaline"
6. "Riluzole delayed appearance of parkinsonian motor abnormalities in a chronic MPTP monkey model"
7. "Prospects of glutamate antagonists in the therapy of Parkinson's disease"
8. "Subthalamic ablation reverses changes in basal ganglia oxidative metabolism and motor response to apomorphine induced by nigrostriatal lesion in rats"
9. "A controlled one-year trial of Dextromethorphan in amyotrophic lateral sclerosis"
10. 2+ influx induced by beta-amyloid peptide 25-35 in cultured hippocampal neurons results from network excitation"
11. "Oxidative damage and metabolic dysfunction in Huntington's disease: Selective vulnerability of the basal ganglia"
12. "Massive persistent release of excitatory amino acids following human occlusive stroke"
13. "Progression of ischaemic stroke and excitotoxic amino acids"
14. "Calcium: Still center-stage in hypoxic-ischemic neuronal death"
15. "Cell culture evidence for neuronal degeneration in amyotrophic lateral sclerosis being linked to glutamate AMPA/kainate receptors"
16. "Glutamate in CNS disorders-a revived target for drug development"
17. "Selfotel in acute ischemic stroke: Possible neurotoxic effects of an NMDA antagonist"
18. "Neuroprotection by dextromethorphan in acute experimental subdural hematoma in the rat"
19. "Anti-glutamate therapy in amyotrophic lateral sclerosis-a trial using lamotrigine"
20. "Dynorphin increases extracellular levels of excitatory amino acids in the brain through a non-opioid mechanism"
21. "The pharmacology of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA) kainate antagonists and their role in cerebral ischaemia"
22. "NMDA receptor antagonists: Past disappointments and future prospects as neuroprotective agents"
23. "Neuroprotection in brain ischemia: An update (part I)"
24. "Neuroprotection in brain ischemia: An update (part II)"
25. "Senile plaques stimulate microglia to release a neurotoxin found in alzheimer brain"
26. "Effect of ischemia on the in vivo release of striatal dopamine, glutamate, and y-aminobutyric acid studied in intracerebral microdialysis"
27. "A clinical trial of dextromethorphan in amyotrophic lateral sclerosis"
28. "N-methyl-D-aspartate antagonists in the treatment of Parkinson's disease"
29. "Glutamate transmission and toxicity in Alzheimer's disease"
30. "Characterization of the excitotoxic potential of the reversible succinate dehydrogenase inhibitor malonate"
31. "1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) decreases glutamate uptake in cultured astrocytes"
32. "Delayed neuronal death and delayed neuronal recovery in the human brain following global ischemia"
33. "Kainic acid induces early and delayed degenerative neuronal changes in rat spinal cord"
34. "Prevention of trauma-induced neurodegeneration in infant and adult rat brain: Glutamate antagonists"
35. "Clinical evaluation of extracellular amino acids in severe head trauma by intracerebral in vivo microdialysis"
36. "Antiglutamate therapies in Huntington's disease"
37. "Combined therapy with flunarizine and memantine of experimental intracerebral hematomas in rats"
38. "A confirmatory dose-ranging study of riluzole in ALS"
39. "Neuroprotective effect of lamotrigine and MK-801 on rat brain lesions induced by 3-nitropropionic acid: Evaluation by magnetic resonance imaging and in vivo proton magnetic resonance spectroscopy"
40. "Glycine antagonist (gavestinel) in neuroprotection (GAIN International) in patients with acute stroke: A randomised controlled trial. GAIN International Investigators"
41. "Glutamate transporter alterations in Alzheimer disease are possibly associated with abnormal APP expression"
42. "Memantine prevents HIV coat protein induced neuronal injury in vitro"
43. "Models of Neuronal Injury in AIDS-another Role for the NMDA receptor"
44. "Neuroprotection in stroke-analysis of failure, and alternative strategies"
45. "beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity"
46. "Protection by memantine against Aβ(1-40)-induced neurodegeneration in Ca1 subfield"
47. "Attenuation of acute and chronic damage following traumatic brain injury in copper, zinc-superoxide dismutase transgenic mice"
48. "Increased transmitter amino acid concentration in human ventricular CSF after brain trauma"
49. "Glutamate in CNS disorders as a target for drug development. An update"
50. "Memantine is a clinically well tolerated N-methyl-D-aspartate (NMDA) receptor antagonist-a review of preclinical data"
51. 2+-permeable AMPA receptors in neurological disorders"
52. "Memantine in moderately severe to severe Alzheimer's disease (AD): Results of a placebo-controlled 6-month trial"
53. "Excitotoxicity and the NMDA receptor"
54. "Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis"
55. "A prospective PMS study to validate the sensitivity for change of the D-scale in advanced stages of dementia using the NMDA-antagonist memantine"
56. "Excitatory amino acids and Parkinson's disease"
57. "Neuroprotective strategies for the treatment of lesions produced by mitochondrial toxins: Implications for neuro degenerative diseases"
58. "Differential vulnerability of central neurons of the rat to quinolinic acid"
59. "Glutamate, excitotoxicity and amyotrophic lateral sclerosis"
60. "NMDA and AMPA receptor antagonists in global and focal ischemia"
61. "Competitive and noncompetitive antagonists at N-methyl-D-aspartate receptors protect against methamphetamine-induced dopaminergic damage in mice"
62. "Blockade of 1-methyl-4-phenylpyridinium ion (MPP+) nigral toxicity in the rat by prior decortication or MK-801 treatment-a stereological estimate of neuronal loss"
63. "Reduction of GluR2 RNA editing, a molecular change that increases calcium influx through AMPA receptors, selective in the spinal ventral gray of patients with amyotrophic lateral sclerosis"
64. "Prevention of HIV-1 gp120-induced neuronal damage in the central nervous system of transgenic mice by the NMDA receptor antagonist memantine"
65. "Protection of substantia nigra from MPP+ neurotoxicity by N-methyl-D-aspartate antagonists"
66. "Amantadine treatment is an independent predictor of improved survival in parkinson's disease"
67. "Riluzole reduces brain lesions and improves neurological function in rats after a traumatic brain injury"
68. "Investigations of neurotoxicity and neuroprotection within the nucleus basalis of the rat"
69. "MK-801, memantine and amantadine show neuroprotective activity in the nucleus basalis magnocellularis"
70. "The effects of mitochondrial failure upon cholinergic toxicity in the nucleus basalis"
71. "Potential therapies for a novel animal model of Alzheimer's disease-Chronic neuroinflamation of transgenic rats that overexpress human β-amyloid"
72. "Evidence that local non-NMDA receptors contribute to functional deficits in contusive spinal cord injury"
73. "Amelioration of functional deficits from spinal cord trauma with systemically administered NBQX, an antagonist of non-N-methyl-D-aspartate receptors"
74. "Delayed antagonism of AMPA/kainate receptors reduces long-term functional deficits resulting from spinal cord trauma"
75. "Beta-amyloid selectively augments NMDA receptor-mediated synaptic transmission in rat hippocampus"
76. "The role of excitatory amino acids in severe brain trauma: Opportunities for therapy: A review"
77. "MK-801 prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in primates"